Catalyst Wire Dossier Catalyst Wire Dossier

Hydrocodone Bitartrate Tablets

hydrocodone bitartrate · Purdue Pharma LP
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hydrocodone Bitartrate Tablets, covering 2014-12-04 to 2014-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. [Phase 3]

See pricing